Trademark: 97352213
Status Date
Thursday, January 25, 2024
Filing Date
Thursday, April 7, 2022
Published for Opposition
Tuesday, December 20, 2022
42 Medical and scientific research, namely, conducting clinical trials for others; pharmaceutical research and development services; medical research; scientific research; providing medical and scientific research information in the field of pharmaceuticals for the treatment of Beta Thalassemia
Jan 25, 2024
Sou Extension 2 Granted
Jan 25, 2024
Sou Extension 2 Filed
Jan 25, 2024
Sou Teas Extension Received
Jul 18, 2023
Notice Of Approval Of Extension Request E-Mailed
Jul 14, 2023
Sou Extension 1 Granted
Jul 14, 2023
Sou Extension 1 Filed
Jul 14, 2023
Sou Teas Extension Received
Feb 14, 2023
Noa E-Mailed - Sou Required From Applicant
Dec 20, 2022
Official Gazette Publication Confirmation E-Mailed
Dec 20, 2022
Published For Opposition
Nov 30, 2022
Notification Of Notice Of Publication E-Mailed
Nov 16, 2022
Approved For Pub - Principal Register
Nov 4, 2022
Teas/Email Correspondence Entered
Nov 4, 2022
Correspondence Received In Law Office
Nov 4, 2022
Teas Response To Office Action Received
Jul 25, 2022
Notification Of Non-Final Action E-Mailed
Jul 25, 2022
Non-Final Action E-Mailed
Jul 25, 2022
Non-Final Action Written
Jul 20, 2022
Assigned To Examiner
Apr 12, 2022
New Application Office Supplied Data Entered
Apr 11, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
